IGF-I Variability Over Repeated Measures in Patients With Acromegaly Under Long-Acting Somatostatin Receptor Ligands.

Luigi MaioneCristina AlbriciSolange GrunenwaldCéline MoulyVincenzo CiminoAnne-Lise LecoqJean Claude SouberbiellePhilippe CaronPhilippe Chanson

Published in: The Journal of clinical endocrinology and metabolism (2022)

In patients treated with long-acting SRLs, IGF-I sampling at the farthest distance from SRL injection is the most informative and best predictor of optimal disease control.

Keyphrases

growth hormone
binding protein
pi k akt
ultrasound guided
signaling pathway